Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders
2016 · Current Opinion in Allergy and Clinical Immunology · 172 citations
https://doi.org/10.1097/aci.0000000000000251
F
Francesco Borriello
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
77
Papers
2.7K
Citations
30
h-index
46
i10-index
Francesco Borriello is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Immunotherapy and Immune Responses & SARS-CoV-2 and COVID-19 Research & Immune Response and Inflammation. The author has an h-index of 30, co-authored 66 publications.
ORCID: 0000-0001-9074-4828Papers by this author
worksAI is a viable alternative to high throughput screening: a 318-target study
2024 · Scientific Reports · 114 citations
https://doi.org/10.1038/s41598-024-54655-z
Prioritized mass spectrometry increases the depth, sensitivity and data completeness of single-cell proteomics
2023 · Nature Methods · 96 citations
https://doi.org/10.1038/s41592-023-01830-1
Controversial role of mast cells in skin cancers
2016 · Experimental Dermatology · 77 citations
https://doi.org/10.1111/exd.13107
Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccination
2022 · Scientific Reports · 21 citations
https://doi.org/10.1038/s41598-022-20346-w
Ocrelizumab during pregnancy and lactation: Rationale and design of the MINORE and SOPRANINO studies in women with MS and their infants
2022 · Multiple Sclerosis and Related Disorders · 18 citations
https://doi.org/10.1016/j.msard.2022.103963
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat